Terri J. Warren
2330 Northwest Flanders, #207
Portland, OR 97210
503-226-6678
[email protected]
Current as of January 2009
EDUCATION
1970 Psychology Tarkio College, Tarkio, Missouri, B.A.
1973 Ed/Counseling Western Oregon University, Monmouth, OR, M.Ed.
1982 Nursing Oregon Health Sciences University, Portland, OR, B.S.N.
1994 Nursing University of Portland, Nurse Practitioner program, M.S.
LICENSURE
RN, Oregon State Board of Nursing, License No. 82011212RN
ANP, Oregon State Board of Nursing, License No. 82011212N3
RN, California Board of Registered Nursing, License No. RN 530313
ANP, California Board of Registered Nursing, License No. 12067
PROFESSIONAL EXPERIENCE
1982-present Owner and Nurse Practitioner, Westover Heights Clinic, Portland, OR 97210
1999-2008 “Expert and responder,” WebMD Genital Herpes Message Board
PUBLICATIONS
Fife KH, Warren TJ, Justus SE, Heitman CK, on behalf of the HS2100275 study team. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients. Sex Transm Dis 2008 Jul; 35(7): 668-673.
Koelle DM, Margaret A, McClurkan CL, Remington ML, Warren T, Teofilovici F, Wald A. Phase I dose escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-Cell responses in HSV-naïve and HSV-2 subjects. Clin Vaccine Immunol 2008 May; 15(5): 773-82.
Bavaro JB, Drolette L, Koelle DM, Almekinder J, Warren T, Tyring S, Wald A. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection. Sex Transm Dis 2008 April; 35(4): 383-386
Sperling RS, Fife KH, Warren TJ, Dix LP, Brennan CA. The effect if daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes. Sex Transm Dis 2008 March; 35(3): 286-290.
Hobbs MM, van der Pol B, Totten P, Gaydos CA, Wald A, Warren T, Winer RL, Cook RL, Deal CD, Rogers ME, Schachter J, Holmes KK, Martin DH. From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for the detection of sexually transmitted infections. Sex Transm Dis 2008 Jan; 35(1): 8-13.
Gupta R, Warren T, Wald A. Genital herpes. Lancet 2007 Dec 22; 370(9605): 2127-37.
Leone P, Warren T, Hamed K, Fife K, Wald A. Famciclovir reduces viral mucosal shedding in HSV-seropositive persons. Sex Transm Dis 2007 Nov; (11): 900-7.
Handsfield HH, Warren T, Werner M, Phillips JA. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life. Sex Transm Dis 2007 Jun; 34(6): 339-43.
Mark KE, Corey L, Meng TC, Margaret AS, Huang ML, Selke S, Slade HB, Tyring SK, Warren T, Sacks SL, Leone P, Bergland VA, Wald A. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial. J Infect Dis 2007 May 1; 195(9):1324-31.
Fife KH, Warren TJ, Ferrera RD, Young DG, Justus SE, Heitman CK, Burroughs SM. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: A US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc 2006 Oct; 81(10):1321-7.
Wald A, Selke S, Warren T, Aoki FY, Sacks S, Diaz-Mitoma F, Corey L. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding. Sex Transm Dis 2006 Sep; 33(9): 529-33.
De Bruyn G, Vargas-Cortez M, Warren T, Tyring SK, Fife KH, Lalezari J, Brady RC, Shahmanesh M, Kinghorn G, Beutner KR, Patel R, Drehobl MA, Horner P, Kurtz TO, McDermott S, Wald A, Corey L. A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects. Vaccine 2006 Feb 13; 24(7): 914-20.
Rana RK, Pimenta JM, Rosenberg DM, Warren T, Sekhin S, Cook SF, Robinson NJ. Sexual behaviour and condom use among individuals with a history of symptomatic genital herpes. Sex Transm Infect 2006; 82:69-74.
Warren T, Ebel C. Counseling the patient who has genital herpes or genital human papillomavirus infection. Infect Dis Clin of N Amer 2005 Jun; 19(2): 459-476.
Warren T, Harris J, Brennan C. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV. Clin Infect Dis 2004 Nov; 39: S258-S266.
Gupta R, Wald A, Kranzt E, Selke S, Warren T, Vargas-Cortes M, Miller G, Corey L. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis 2004 Oct 15; 190(8): 1374-81.
Warren T. Herpes Simplex virus testing is necessary. The Female Patient 2004 Jan; 29: 6-7.
Corey L, Wald A, Patel R, Sacks S, Tyring S, Warren T, Douglas JM Jr, Paavonen J, Morrow RA, Beutner KR, Stratchounsky LS, Mertz G, Keene ON, Watson HA, Tait D, Vargas-Cortes M; Valacyclovir HSV Transmission Study Group. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004 Jan 1; 350(1): 11-20.
DeJesus E, Wald A, Warren T, Schacker TW, Trottier S, Shahmanesh M, Hill JL, Brennan CA; Valacyclovir International Study Group. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects. J Infect Dis 2003 Oct 1; 188(7): 1009-16.
Warren T. Psychosocial issues in the management of genital herpes. The Female Patient 2003 April; 10-18.
Wald A, Zeh J, Selke S, Warren T, Ashley R, Corey L. Genital shedding of herpes simplex virus among men. J Infect Dis 2002 Oct 15; 186 Suppl 1: S34-9.
Warren T. The Last Word: Getting tested for herpes. FDA Consum 2002 Mar Apr; 36(2): 40.
Khatamee M, Brown Z, Warren T. Management of herpes simplex virus and pregnancy. Suppl to the J of Gen Spec Med 2001 Sep.
Wald A, Langenberg AG, Link K, Izu AE, Ashley R, Warren T, Tyring S, Douglas JM Jr, Corey L. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001 Jun 27; 285(24): 3100-6.
Wald A, Zeh J, Selke S, Warren T, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342: 844-850.
Corey L, Langenberg A, Ashley R, Warren T, et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 Infection. JAMA 1999 July; 282: 331-340.
Lekstrom-Himes JA, Hohman P, Warren T, et al. Association of major histocompatibility complex determinants with the development of symptomatic and asymptomatic genital herpes simplex virus type 2 infections. J of Infect Dis 1999 May; 179: 1077-85.
Warren T, Warren R. Tender Talk: A guide to intimate conversations. Portland Press. 1985.
Warren T, Warren R. The Updated Herpes Handbook. Portland Press. 1985-2007.
PROFESSIONAL AFFILIATIONS
Herpes Scientific Advisory Committee, American Social Health Association
HPV Scientific Advisory Committee, American Social Health Association
Oregon Nurses Association
Nurse Practitioners of Oregon
American Sexually Transmitted Disease Association
International Society for Antiviral Research
Association of Reproductive Health Professionals
IUSTI Member
American Society for Microbiology
PERSONAL AFFILIATION
Sierra Club
National Public Radio Cornerstone Society
League of Women Voters
Planned Parenthood Supporting Member
